Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Ladoire

Showing results (51-60 of 167) with videos related to

Pageof 17
Sort By:
Breast (Edinburgh, Scotland)|February 11, 2023
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival resultsManon Réda, Anaïs Fouquier, Isabelle Desmoulins, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Population Pharmacokinetics of Palbociclib in aReal-World SituationBernard Royer, Courèche Kaderbhaï, Jean-David Fumet, et al.
Critical Care Medicine|September 15, 2007
Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumoniaJean-Pierre Quenot, Sylvain Ladoire, Fabrice Devoucoux, et al.
Oncotarget|October 10, 2015
Liver X receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localizationFlavie Courtaut, Valentin Derangère, Angélique Chevriaux, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2013
Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trialsSylvain Ladoire, Cecile Dalban, Henri Roché, et al.
BMJ Open|September 28, 2022
Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocolEmerline L F Assogba, Agnès Dumas, Anne-Sophie Woronoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-AnalysisCharles Guenancia, Annick Lefebvre, Daniela Cardinale, et al.
Anticancer Research|November 2, 2010
Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxel failureSylvain Ladoire, Jean Christophe Eymard, Sylvie Zanetta, et al.
Journal for Immunotherapy of Cancer|November 21, 2018
RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancerFanny Ledys, Quentin Klopfenstein, Caroline Truntzer, et al.
Breast Cancer (Tokyo, Japan)|January 30, 2023
HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based studySamia Kada Mohammed, Oumar Billa, Sylvain Ladoire, et al.
Pageof 17

Showing results (51-60 of 167) with videos related to

Sort By:
Pageof 17
Breast (Edinburgh, Scotland)|February 11, 2023
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival resultsManon Réda, Anaïs Fouquier, Isabelle Desmoulins, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Population Pharmacokinetics of Palbociclib in aReal-World SituationBernard Royer, Courèche Kaderbhaï, Jean-David Fumet, et al.
Critical Care Medicine|September 15, 2007
Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumoniaJean-Pierre Quenot, Sylvain Ladoire, Fabrice Devoucoux, et al.
Oncotarget|October 10, 2015
Liver X receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localizationFlavie Courtaut, Valentin Derangère, Angélique Chevriaux, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2013
Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trialsSylvain Ladoire, Cecile Dalban, Henri Roché, et al.
BMJ Open|September 28, 2022
Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocolEmerline L F Assogba, Agnès Dumas, Anne-Sophie Woronoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-AnalysisCharles Guenancia, Annick Lefebvre, Daniela Cardinale, et al.
Anticancer Research|November 2, 2010
Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxel failureSylvain Ladoire, Jean Christophe Eymard, Sylvie Zanetta, et al.
Journal for Immunotherapy of Cancer|November 21, 2018
RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancerFanny Ledys, Quentin Klopfenstein, Caroline Truntzer, et al.
Breast Cancer (Tokyo, Japan)|January 30, 2023
HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based studySamia Kada Mohammed, Oumar Billa, Sylvain Ladoire, et al.
Pageof 17